| [1] |
Young RJ, Brown NJ, Reed MW, et al. Angiosarcoma[J]．Lancet Oncol, 2010, 11(10): 983-991.
|
| [2] |
Abdou Y, Elkhanany A, Attwood K, et al. Primary and secondary breast angiosarcoma: single center report and a meta-analysis[J]．Breast Caner Res Treat, 2019, 178(3): 523-533.
|
| [3] |
Vorburger SA, Xing Y, Hunt KK, et al. Angiosarcoma of the breast[J]. Cancer, 2005, 104(12)：2682-2688.
|
| [4] |
Arora TK, Terracina KP, Soong J, et al. Primary and secondary angiosarcoma of the breast[J]．Gland Surg, 2014, 3(1): 28-34.
|
| [5] |
Taffurelli M, Pellegrini A, Meattini I, et al. Secondary breast angiosarcoma: A multicentre retrospective survey by the national Italian association of Breast Surgeons (ANISC)[J]. Breast, 2019, 45: 56-60.
|
| [6] |
Huang J, Mackillop WJ.Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma[J]. Cancer, 2001, 92(1): 172-180.
|
| [7] |
Gross JP，Sachdev S，Helenowski IB，et al. Radiation therapy field design and lymphedema risk after regional nodal irradiation for breast cancer[J]. Int J Radiat Oncol Biol Phys，2018，102(1): 71-78.
|
| [8] |
Karlsson P, Holmberg E, Samuelsson A, et al. Soft tissue sarcoma after treatment for breast cancer—a Swedish population-based study[J]．Eur J Cancer, 1998, 34(13): 2068-2075.
|
| [9] |
Baker GM, Schnitt SJ. Vascular lesions of the breast[J]．Semin Diagn Pathol，2017，34(5)：410-419.
|
| [10] |
Mentzel T, Schildhaus HU, Palmedo G, et al. Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: clinicopathological, immunohistochemical and molecular analysis of 66 cases[J]．Mod Pathol，2012，25(1)：75-85.
|
| [11] |
Requena C, Alsina M, Morgado-Carrasco D, et al. Kaposi sarcoma and cutaneous angiosarcoma: guidelines for diagnosis and treatment[J]. Actas Dermosifiliogr (Engl Ed), 2018, 109(10): 878-887.
|
| [12] |
Esposito E, Avino F, di Giacomo R, et al. Angiosarcoma of the breast, the unknown-a review of the current literature[J]. Transl Cancer Res, 2019, 8(Suppl 5): S510-S517.
|
| [13] |
Folpe AL, Chand EM, Goldblum JR, et al. Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics[J]. Am J Surg Pathol, 2001, 25(8): 1061-1066.
|
| [14] |
Brooks TA, Hurley LH. The role of supercoiling in transcriptional control of MYC and its importance in molecular therapeutics[J]. Nat Rev Cancer, 2009, 9(12): 849-861.
|
| [15] |
Manner J, Radlwimmer B, Hohenberger P, et al. MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema [J]. Am J Pathol, 2010, 176(1): 34-39.
|
| [16] |
Rosenthal J, Cardona K, Sayyid SK. et al. Nodal metastases of soft tissue sarcomas: risk factors, imaging findings, and implications[J]. Skeletal Radiol，2020, 49(2): 221-229.
|
| [17] |
Scott MT, Portnow LH, Morris CG, et al. Radiation therapy for angiosarcoma: the 35-year University of Florida experience[J]. Am J Clin Oncol, 2013, 36(2): 174-180.
|
| [18] |
Yin M, Wang W, Drabick JJ, et al. Prognosis and treatment of non-metastatic primary and secondary breast angiosarcoma: a comparative study[J]. BMC Cancer, 2017, 17(1): 295.
|
| [19] |
Torres KE, Ravi V, Kin K, et al. Long-term outcomes in patients with radiation-associated angiosarcomas of the breast following surgery and radiotherapy for breast cancer[J]. Ann Surg Oncol, 2013, 20(4): 1267-1274.
|